Literature DB >> 19445544

The Dutch Medicines for Children Research Network: a new resource for clinical trials.

Elske H Weber1, Ivo T F Timmermans, Martin Offringa.   

Abstract

In Europe, several national networks have been established to undertake clinical research of medicines for children. In the Netherlands, the Dutch Medicines for Children Research Network (MCRN) was launched in September 2008. The purpose of the Dutch MCRN is to improve the speed, quality, and coordination of clinical drug research in children, ultimately resulting in better patient care.

Entities:  

Mesh：

Year:  2009        PMID： 19445544     DOI： 10.2165/00148581-200911030-00001

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN： 1174-5878            Impact factor:   3.022


  7 in total

1.  Progress and deficiencies in the registration of clinical trials.

Authors:  Alastair J J Wood
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 91.245

2.  [Better medicines for children: European measures].

Authors:  H van den Berg; J A J M Taminiau
Journal:  Ned Tijdschr Geneeskd       Date:  2008-07-05

3.  Off-label indications for medication use and the published literature.

Authors:  Rebecca Dresser
Journal:  JAMA       Date:  2008-09-24       Impact factor: 56.272

Review 4.  Development of medicines for children in Europe: ethical implications.

Authors:  Agnès Saint Raymond; Daniel Brasseur
Journal:  Paediatr Respir Rev       Date:  2005-03       Impact factor: 2.726

5.  German Paediatric Research Network (PAED-Net).

Authors:  Monika Seibert-Grafe; Raunhild Butzer; Fred Zepp
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

6.  Children are not just small adults: the urgent need for high-quality trial evidence in children.

Authors:  Terry P Klassen; Lisa Hartling; Jonathan C Craig; Martin Offringa
Journal:  PLoS Med       Date:  2008-08-12       Impact factor: 11.069

7.  Next stop, don't block the doors: opening up access to clinical trials results.

Authors: 
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069
  7 in total
  2 in total

1.  Understanding the value of information from pediatric clinical research.

Authors:  Wendy J Ungar
Journal:  Paediatr Drugs       Date:  2012-10-01       Impact factor: 3.022

2.  Multidisciplinarity goes mainstream: Orlando meeting of the Pediatric Pharmacy Advocacy Group focuses attention on the need for multidisciplinary networks.

Authors:  Stuart Macleod; David Knoppert
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.